Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.2M Sell
5,416
-100
-2% -$24.5K 0.01% 227
2025
Q4
$1.4M Hold
5,516
0.01% 221
2025
Q3
$1.36M Sell
5,516
-703
-11% -$168K 0.01% 220
2025
Q2
$1.49M Sell
6,219
-100
-2% -$23.3K 0.01% 215
2025
Q1
$1.43M Sell
6,319
-290
-4% -$63.8K 0.01% 220
2024
Q4
$1.36M Sell
6,609
-200
-3% -$43.9K 0.01% 224
2024
Q3
$1.65M Sell
6,809
-375
-5% -$87.7K 0.01% 225
2024
Q2
$1.58M Sell
7,184
-150
-2% -$32.6K 0.01% 220
2024
Q1
$1.65M Sell
7,334
-350
-5% -$78.9K 0.01% 220
2023
Q4
$1.69M Sell
7,684
-1,019
-12% -$216K 0.01% 219
2023
Q3
$1.91M Sell
8,703
-362
-4% -$81.9K 0.01% 206
2023
Q2
$2.04M Sell
9,065
-1,279
-12% -$256K 0.01% 210
2023
Q1
$1.98M Sell
10,344
-143
-1% -$27.6K 0.01% 215
2022
Q4
$1.94M Sell
10,487
-1,105
-10% -$194K 0.01% 216
2022
Q3
$1.93M Sell
11,592
-1,101
-9% -$224K 0.01% 210
2022
Q2
$2.62M Sell
12,693
-482
-4% -$109K 0.02% 195
2022
Q1
$3.19M Sell
13,175
-1,312
-9% -$304K 0.02% 189
2021
Q4
$3.53M Sell
14,487
-5
-0% -$1.14K 0.02% 191
2021
Q3
$2.96M Buy
14,492
+267
+2% +$57.1K 0.02% 200
2021
Q2
$2.94M Sell
14,225
-327
-2% -$65.8K 0.02% 207
2021
Q1
$2.77M Sell
14,552
-2,859
-16% -$530K 0.02% 211
2020
Q4
$3.3M Sell
17,411
-33
-0.2% -$6.16K 0.02% 197
2020
Q3
$3.07M Sell
17,444
-443
-2% -$70.8K 0.02% 190
2020
Q2
$2.75M Buy
17,887
+401
+2% +$61.1K 0.02% 190
2020
Q1
$2.45M Sell
17,486
-5,303
-23% -$793K 0.02% 189
2019
Q4
$3.47M Sell
22,789
-790
-3% -$116K 0.02% 187
2019
Q3
$3.41M Sell
23,579
-1,285
-5% -$192K 0.02% 178
2019
Q2
$3.7M Sell
24,864
-500
-2% -$66.8K 0.03% 170
2019
Q1
$3.25M Buy
25,364
+410
+2% +$48.3K 0.03% 170
2018
Q4
$2.67M Sell
24,954
-1,420
-5% -$159K 0.03% 169
2018
Q3
$3.02M Sell
26,374
-407
-2% -$46K 0.04% 173
2018
Q2
$2.81M Sell
26,781
-66
-0.2% -$6.64K 0.03% 178
2018
Q1
$2.51M Sell
26,847
-1,470
-5% -$134K 0.03% 186
2017
Q4
$2.48M Sell
28,317
-25
-0.1% -$2.23K 0.03% 187
2017
Q3
$2.5M Sell
28,342
-400
-1% -$33.9K 0.03% 177
2017
Q2
$2.34M Sell
28,742
-705
-2% -$53.6K 0.03% 174
2017
Q1
$2.04M Sell
29,447
-275
-0.9% -$19K 0.02% 182
2016
Q4
$2M Sell
29,722
-2,985
-9% -$202K 0.02% 177
2016
Q3
$2.39M Sell
32,707
-2,225
-6% -$157K 0.03% 160
2016
Q2
$2.4M Sell
34,932
-5,345
-13% -$374K 0.03% 155
2016
Q1
$2.86M Sell
40,277
-18,879
-32% -$1.28M 0.04% 142
2015
Q4
$4.46M Sell
59,156
-830
-1% -$60K 0.06% 119
2015
Q3
$3.9M Buy
59,986
+1,865
+3% +$123K 0.06% 130
2015
Q2
$3.75M Sell
58,121
-2,455
-4% -$166K 0.05% 131
2015
Q1
$4.26M Sell
60,576
-661
-1% -$43.6K 0.06% 124
2014
Q4
$3.97M Buy
61,237
+265
+0.4% +$16.4K 0.06% 129
2014
Q3
$3.29M Buy
60,972
+1,350
+2% +$73.4K 0.05% 139
2014
Q2
$3.19M Sell
59,622
-850
-1% -$43.8K 0.05% 138
2014
Q1
$2.89M Buy
60,472
+323
+0.5% +$15.1K 0.05% 145
2013
Q4
$2.89M Buy
60,149
+4,035
+7% +$184K 0.05% 143
2013
Q3
$2.41M Buy
56,114
+1,505
+3% +$65.4K 0.04% 147
2013
Q2
$2.34M Buy
+54,609
New +$2.35M 0.04% 144

Other funds holding STE

Bahl & Gaynor's STE Position: Q1 2026 in Review

Bahl & Gaynor reduced its Steris (STE) stake by 1.8% in Q1 2026, selling an estimated $24.5K and leaving 5,416 shares worth $1.2M. The position accounts for 0.01% of the portfolio, ranked #227.

Bahl & Gaynor first reported a position in STE in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.46M in Q4 2015. 843 funds tracked by Wall St. Rank hold STE as of Q1 2026.

  • Bahl & Gaynor held 5,416 shares of Steris worth $1.2M as of Q1 2026.
  • Bahl & Gaynor sold 100 Steris shares in Q1 2026, an estimated $24.5K.
  • Steris made up 0.01% of Bahl & Gaynor's portfolio in Q1 2026, its #227 holding.
  • Bahl & Gaynor first reported a position in Steris in Q2 2013 and has held it in 52 quarters since.
  • Bahl & Gaynor's Steris position peaked at $4.46M in Q4 2015.
  • 843 funds tracked by Wall St. Rank held Steris as of Q1 2026.

Based on Bahl & Gaynor's 13F filing for Q1 2026, filed 7 May 2026.